celecoxib has been researched along with Leukemic Infiltration in 1 studies
Leukemic Infiltration: A pathologic change in leukemia in which leukemic cells permeate various organs at any stage of the disease. All types of leukemia show various degrees of infiltration, depending upon the type of leukemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukemia the skin is often infiltrated. The central nervous system too is a common site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In celecoxib-treated mice, interferon-gamma (IFN-gamma) production from MOG-specific T cells was reduced and MOG-specific IgG1 was elevated compared with vehicle-treated mice." | 1.33 | Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. ( Kusunoki, S; Miyake, S; Miyamoto, K; Mizuno, M; Oka, N; Yamamura, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, K | 1 |
| Miyake, S | 1 |
| Mizuno, M | 1 |
| Oka, N | 1 |
| Kusunoki, S | 1 |
| Yamamura, T | 1 |
1 other study available for celecoxib and Leukemic Infiltration
| Article | Year |
|---|---|
Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway.
Topics: Animals; Celecoxib; Cell Adhesion Molecules; Central Nervous System; Chemokine CCL2; Cyclooxygenase | 2006 |